Invicta Diagnostic's IPO debuted strongly on December 8, listing at ₹100, a 17.65% premium over its issue price of ₹85. The ...

Shares of Invicta Diagnostic listed at Rs 100 per share on the Emerge platform of the National Stock Exchange (NSE). The Rs 28.12 crore issue had a price band of Rs 80-85 per share.

Invicta Diagnostic was trading at Rs 95 on the NSE, a 11.76% premium to the issue price of Rs 85. Invicta Diagnostic's IPO was subscribed 4.05 times. The issue opened for bidding on 1 December 2025 ...

Invicta Diagnostics IPO opened on December 1 and will close on December 3, looking to raise ₹28 crore. The company plans to ...

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...

Invicta Diagnostic is set to debut on the NSE SME platform on December 8, following a successful IPO that raised 28.12 crore.

A recently disclosed Tri-Century Eye Care data breach stemming from a ransomware attack affects roughly 200,000 individuals.

Owensboro Community & Technical College (OCTC) is expanding its Automotive Technology program with new courses this semester.

Discover 10 high-paying, hard-to-fill jobs offering $30+ an hour, what's driving the demand, and how these roles could boost ...

An owner of a newer Hyundai Ioniq 5 N is raising awareness of a Right to Repair-related issue tied to the general maintenance ...

AI systems are racing through standardized tests, acing bar exams and coding challenges that once seemed safely human. Yet in daily life, the same tools still hallucinate facts, misread context and ...

MIDDLETON, Wis., Dec. 3, 2025 /PRNewswire/ -- Natus Medical Incorporated announced the electrographic status epilepticus diagnosis capability of its BrainWatch point-of-care EEG solution, featuring ...